Search Results - "Barbour, Robin M."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis by Renz, Mark, Torres, Ronald, Dolan, Philip J., Tam, Stephen J., Tapia, Jose R., Li, Lauri, Salmans, Joshua R., Barbour, Robin M., Shughrue, Paul J., Nijjar, Tarlochan, Schenk, Dale, Kinney, Gene G., Zago, Wagner

    Published in Amyloid (02-07-2016)
    “…Amyloid light chain (AL) amyloidosis is characterized by misfolded light chain (LC) (amyloid) deposition in various peripheral organs, leading to progressive…”
    Get full text
    Journal Article
  2. 2

    Anti-Mcam Monoclonal Antibody PRX003 Inhibits the Unique Migratory Potential of Pathogenic IL-17–Producing T Cells by Flanagan, Kenneth, Tam, Stephen J, Li, Lauri, Dolan, Philip J, Barbour, Robin M, Higaki, Jeffrey N, Liu, Yue, Nijjar, Tarlochan, Skov, Michael, Zago, Wagner, Yednock, Ted A, Kinney, Gene F, Ness, Dan

    Published in Journal of allergy and clinical immunology (01-02-2016)
    “…Rationale Melanoma cell adhesion molecule (MCAM) expression on a small subset of memory CD4+/CD8+ T cells defines their ability to secrete IL-17 and identifies…”
    Get full text
    Journal Article
  3. 3

    Immunological response to dual Aβ/Tau vaccine PRX123 surrogate and effects on brain amyloid plaques in rapidly depositing transgenic animal model by Tourino, Clara, Trumble, Alyssa, Louie, LeeAnn, Barbour, Robin M., Kinney, Gene G., Campbell, Brian, Zago, Wagner M.

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Alzheimer’s disease (AD) is defined by hallmark features including Aβ plaque deposits and tau tangles throughout the brain. Clinical evidence…”
    Get full text
    Journal Article
  4. 4

    Development of a dual Aβ‐tau vaccine for the prevention of Alzheimer’s disease by Barbour, Robin M, Bard, Frederique, Elmaarouf, Abderrahman, Louie, LeeAnn, Prill, Heather, Thomas, Kimberly, Kinney, Gene G, Zago, Wagner M

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Alzheimer’s disease (AD) is characterized by two pathological hallmarks, Aβ plaques and tau tangles. Several antibodies targeting Aβ plaques showed…”
    Get full text
    Journal Article
  5. 5

    NEOD001 Specifically Binds Aggregated Light Chain Infiltrates in Multiple Organs from Patients with AL Amyloidosis and Promotes Phagocytic Clearance of AL Aggregates in Vitro by Zago, Wagner, Renz, Mark, Torres, Ronald, Dolan, Philip J., Barbour, Robin M., Salmans, Joshua R., Shughrue, Paul J., Schenk, Dale, Kinney, Gene G.

    Published in Blood (03-12-2015)
    “…Background: Light chain (AL) amyloidosis is the most common form of systemic amyloidosis and is characterized by the accumulation of aggregated, misfolded…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay by Henriksson, T, Barbour, R M, Braa, S, Ward, P, Fritz, L C, Johnson-Wood, K, Chung, H D, Burke, W, Reinikainen, K J, Riekkinen, P

    Published in Journal of neurochemistry (01-03-1991)
    “…One of the major clinical findings in Alzheimer's disease (AD) is the formation of deposits of beta-amyloid protein in amyloid plaques, derived from the…”
    Get more information
    Journal Article